This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Health Canada.Health Canada examining information linking antiviral drug to development of treatment-resistant HIV. Media Release: 21 Feb 2007. Available from: URL: http://www.hc-sc.gc.ca
About this article
Cite this article
Health Canada has informed Canadians of a possible link between Baraclude [entecavir] and the development of a treatment-resistant HIV strain. React. Wkly. 1141, 2 (2007). https://doi.org/10.2165/00128415-200711410-00004
- Public Health
- Virus Level
- Safety Recommendation